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Conglutins represent the major peanut allergens and are renowned for their resistance to gastro-
intestinal digestion. Our aim was to characterize the digestion-resistant peptides (DRPs) of conglutins 
by biochemical and biophysical methods followed by a molecular dynamics simulation in order to better 
understand the molecular basis of food protein allergenicity. We have mapped proteolysis sites at the 
N- and C-termini and at a limited internal segment, while other potential proteolysis sites remained 
unaffected. Molecular dynamics simulation showed that proteolysis only occurred in the vibrant regions 
of the proteins. DRPs appeared to be conformationally stable as intact conglutins. Also, the overall 
secondary structure and IgE-binding potency of DRPs was comparable to that of intact conglutins. The 
stability of conglutins toward gastro-intestinal digestion, combined with the conformational stability of 
the resulting DRPs provide conditions for optimal exposure to the intestinal immune system, providing 
an explanation for the extraordinary allergenicity of peanut conglutins.
Peanut allergens have been extensively studied for decades for their biological and immunologic properties1. 
Peanut conglutins, Ara h 2 and Ara h 6, represent the allergens recognized by the majority of peanut allergic 
patients2. These allergens are far more potent than other peanut allergens like Ara h 1 and Ara h 3, as was shown 
by effector cell activation and in vivo in human skin2,3. Ara h 2 and Ara h 6 together are responsible for 80–90% 
of the allergenic activity of the total peanut extract as determined by activation of basophils using a rat basophil 
leukemia cell line assay with IgE from peanut allergic patients4–7. Ara h 2 was described as pre-eminent in impor-
tance because it was identified as a predictor of clinical reactivity to peanut8–11. Recently, it was shown that Ara h 
6 is good predictor of clinical reactivity too, and complements Ara h 2 for IgE reactivity10,12.
Ara h 2 and Ara h 6 are 2S albumins with four tightly coiled helical structures that form a heat- and 
protease-stable core13. They are isoforms of each other with 59% sequence homology14. Ara h 2 exists in two iso-
forms, Ara h 2.02 and Ara h 2.0115,16, with reported masses of 18032 Da and 16341 Da, respectively, determined 
by mass spectrometry17. In comparison with Ara h 2.01, Ara h 2.02 has an insertion of 12 amino acids, starting at 
residue 54 containing the linear IgE-binding epitope, DPYSPS18. For Ara h 2, site-specific proline hydroxylation 
has been reported earlier, together with the mapping of disulphide linkages19. Ara h 6 has a determined mass of 
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14835 Da17,20. It has been shown that conglutin isoforms from peanut are very resistant to gastro-intestinal (GI) 
digestion, even after heat treatment13,20–23.
Peanut allergens have been detected in breast milk by immunoassays, suggesting that at least some of the 
immunoreactive domains of these peanut allergens remain intact during uptake by intestinal epithelium and entry 
into the circulatory system24,25. Earlier studies showed that digestion of conglutins results in digestion-resistant 
peptides (DRPs) with approximate masses of 10 kDa13,20, regardless whether gastric or intestinal proteases were 
used22,23,26. The digestion-resistant peptide from Ara h 2 (DRP-Ara h 2) could be detected in serum from health 
individuals for up to 24 hours after ingestion, while the presence of intact peanut protein could not be demon-
strated27. Transfusion-related anaphylaxis occurred due to the passive transfer of peanut allergen present in donor 
blood to a peanut-allergic recipient, indicating in vivo functionality of peanut allergen circulating in blood after 
ingestion28. Although the main part of the in vivo studies was done with an immunoassay directed against Ara h 
2, the exact nature of the peanut allergen found in the circulation is not known. Still there is limited information 
on primary sequence of the DRPs.
The aim of this study is to identify the digestion resistant peptides for each of the naturally occurring conglu-
tins Ara h 2.01, Ara h 2.02, and Ara h 6 in order to understand the epitope diversity of these major peanut aller-
gens. Furthermore, we applied a molecular dynamics simulation to understand the cleavage sites of the protease 
and the effects of the digestion on the overall conformational stability and conformational IgE-binding epitopes 
of these peanut allergens.
Results
Trypsin digestion gives stable, digestion-resistant peptides (DRPs) for all conglutin isoforms. 
Peanut conglutin isoforms, Ara h 2.02, Ara h 2.01 and Ara h 6, were digested by incubation with trypsin. 
Supplementary Fig. S1 shows the time course of the digestion as visualized by Sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE) under reducing conditions. The peptides originating from the digestion 
remain stable up to the 180 minutes endpoint of our study for all of the conglutin isoforms. DRPs of the Ara h 2.02 
isoform consist of two groups, with apparent molecular masses of approximately 12 kDa, and 10 kDa. DRPs from 
Ara h 2.01 exhibit an apparent molecular weight of approximately 10 kDa and careful examination of this area 
reveals two co-migrating bands. DRPs from Ara h 6 migrate as approximately 9 kDa and 5 kDa bands. For further 
characterization, DRPs prepared by digestion for 90 minutes were used. Under physiological conditions using 
pepsin at low pH followed by trypsin/chymotrypsin at neutral pH, peanut conglutins are resistant to proteolysis 
as well. The resulting DRPs have similar molecular weights as the ones analyzed in our study, and can still bind 
IgE (data not shown), in accordance to other studies13,22.
Identification of sequences of DRPs from peanut conglutin isoforms. High-resolution mass spec-
tra were recorded for non-reduced and reduced- and alkylated DRPs from Ara h 2 isoforms, Ara h 2.02 and Ara 
h 2.01, and Ara h 6. ESI-MS spectra of non-reduced and reduced- and alkylated DRPs are shown in Figs 1 and 
2, respectively. For non-reduced DRPs, a wide range of m/z ions with higher charge states (from + 8 to + 17) 
is observed, which represent masses with molecular masses >13 kDa. The mass spectra for these non-reduced 
DRPs also contain m/z ions with lower charge states (from + 2 to + 6), representing the masses < 5 kDa. Reduced 
and alkylated DRPs give a charge state range from + 4 to + 12, representing the masses from 2.2–10 kDa. In the 
spectra of the reduced and alkylated DRPs, it can be observed that one charge state ion gives several m/z masses, 
deviating 57 Da from each other. This relates to partial alkylation of cysteines. The Supplementary Table S1 sum-
marizes the masses found for the DRPs, both from non-reduced and reduced and alkylated form. Trypsinolysis 
of Ara h 2.02 and 2.01 led to DRPs of molecular masses from 16.2–17.6 kDa, as well as to some small peptides 
from 2–4 kDa (see Supplementary Table S1). Ara h 6 showed DRPs of molecular masses from 13.5–14.1 kDa. 
Taking into account the known post-translational modification, post-translational processing and combining of 
the masses of intact and reduced and alkylated DRP using the mapping of disulphide bonds19, the experimental 
masses were linked to theoretical masses (see Supplementary Table S1).
Two dimensional electrophoresis (2-DE) profiles of DRPs from individual conglutin isoforms (see 
Supplementary Fig. S2) were used to assign spots, where different pI values of DRPs provided additional direc-
tions for peptide verification. Figure 3 provides an overview of the peptide sequences found in the DRPs of 
the three peanut conglutins. After digestion we have detected proteins with one peptide bond hydrolysed on 
the Arg59/71 for Ara h 2 and Arg50 for Ara h 6 (Fig. 3. Panel a - Ara h 2.02, peptides a, and b; Panel b - Ara h 
2.01, peptides b, c, d, and e; Panel c - Ara h 6, peptides a, and b), which after reduction yields two peptides with 
molecular weights from 7.2–9.7 kDa for Ara h 2 and 4.8-9.4 kDa for Ara h 6. In the intact DRPs from Ara h 2, a 
C-terminal proteolytic processing of the Y/RY fragment was observed29, but also cleavage at the trypsin cleav-
age site Arg149/137-Asp150/138. Additionally, peptides with deleted internal short segments (S48TR50 in Ara h 6 and 
D61PYSPSPYDRR71 in Ara h 2.02) were detected. In DRPs from Ara h 2, internal segments were detected starting 
at Asp35 or Asp42 (Fig. 3. Panel a – Ara h 2.02 peptides f, g and h, Panel b – Ara h 2.01 peptide f). These short pep-
tides do not contain cysteine residues and do not remain associated to the stable protein core. The N-terminus of 
the Ara h 6 after digestion showed some diversity of N-terminus (proteolysis at Arg5 or Arg7, Fig. 3. Panel c – Ara 
h 6 peptides a–d). For all three conglutins, the most digestion-susceptible parts are the N- and C-terminus, and 
to a lesser extent a limited internal part. It is evident that in all three conglutin isoforms, the main internal site 
of trypsin attack is structurally identical (R59|R60|D61PYSPSPYDRR71|G72 in Ara h 2.02, R58|R59|G60 in Ara h 2.01 
and R47|S48TR50|S51 in Ara h 6), located in the loop that bears no defined local structure. Supplementary Fig. S3 
contains sequence alignment of the conglutin isoforms with assignment of secondary structure elements and 2D 
topology diagram showing the disulphide bridges.
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The secondary structure of the peanut conglutin isoforms is not affected by digestion and 
molecular dynamic simulation reveals conformationally stable structures of DRPs. Far UV 
Circular dichroism (CD) spectra were acquired at pH 8 and pH 1.2, at 37 °C, in order to gain better understanding 
of the structural properties of DRPs of Ara h 2.02, Ara h 2.01 and Ara h 6. The spectra of the three native isoforms 
Figure 1. ESI-MS spectra of non-reduced DRPs. Non-reduced DRPs were subjected to ESI-MS to determine 
masses of individual peptides. Peptides may be linked by disulphide bonds. Panel a: DRPs of Ara h 2.02; Panel b: 
DRPs of Ara h 2.01; Panel c: DRPs of Ara h 6.
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show a strong positive ellipticity from 200 to 190 nm, typically indicating the presence of α -helical structures 
(line plots in Fig. 4). The shape of the far UV CD spectra of DRPs is similar to that of native proteins (dashes plots 
in Fig. 4). The zero-crossing, i.e. the wavelength at 0 mdeg ellipticity, is the same for DRPs and native isoforms, 
confirming that no notable change in secondary structure occurred as a result of degradation of the intact protein 
Figure 2. ESI-MS spectra of reduced and alkylated DRPs. Reduced and alkylatd DRPs were subjected to 
ESI-MS to determine masses of individual peptides. Panel a: DRPs of Ara h 2.02; Panel b: DRPs of Ara h 2.01; 
Panel c: DRPs of Ara h 6.
www.nature.com/scientificreports/
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into smaller fragments. Native conglutins and their DRPs have highly comparable far UV CD spectra at neutral 
pH and low pH, indicating that no denaturation occurs in the stomach.
To analyse the consequences of the proteolytic action for the three isoforms, a molecular dynamics simulation 
was performed on both the intact and digested proteins for 500 ns for Ara h 2 and 800 ns for Ara h 6. According 
to backbone root mean square fluctuations (RMSF), it can be noticed that both isoforms of Ara h 2 have three 
regions with high mobility: the flanking N-terminal part up to the first Cys, the C-terminal part from the last 
Cys residue to the end of the sequence, and a region which is almost the entire unstructured loop between sec-
ond and third Cys residue (Fig. 5a,b). The mobility of Ara h 6 regions is similar, except that the C-terminal part 
is not mobile due to a disulphide located at the C-terminus of the protein (Fig. 5c). Trypsin cleavage sites are 
Figure 3. Sequences of the DRPs as determined by nanoLC-MS. Using the sequence of the intact conglutins 
(top line of each panel), the identified peptides are shown by subsequent lines (indicated with letters). Each line 
represents a unique peptide found. Lines marked with ‘R’ represent peptides that are released from the protein 
core upon digestion. Panel a: Sequences of the DRPs from Ara h 2.02 protein species; Panel b: Sequences of the 
DRPs from Ara h 2.01 protein species; Panel c: Sequences of the DRPs from Ara h 6 protein species.
Figure 4. Far UV CD spectra of DRPs versus native conglutin isoforms. Native conglutins and their DRPs 
were analysed by far UV CD spectroscopy to investigate secondary structure content, both at neutral pH and 
low pH to mimic gastric and duodenal conditions. Solid lines represent native peanut conglutins; dotted lines 
represent DRPs from the respective conglutins. Top panels (a,b,c) at pH = 8.0, lower panels (d,e,f) at pH= 1.2. 
Left panels (a,d): Ara h 2.02; Middle panels (b,e): Ara h 2.01; Right panels (c,f): Ara h 6.
www.nature.com/scientificreports/
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marked with an arrow in Fig. 5 for the DRPs and these are considered for further molecular dynamics analysis. 
Furthermore, Fig. 5d–f show trypsin-sensitive cleavage sites for all DRPs identified in this study (Fig. 3). It can 
be observed that RMSF values of almost all trypsin-sensitive sites found in this study are higher than 0.60 Å, 
(Fig. 5d–f), while trypsin resistant sites are virtually all showing RMSF values smaller than 0.70 Å. In fact, the 
positive predictive value for the susceptibility of target cut sites in peanut conglutins to trypsinolysis is 83%, for 
resistance to proteolytic action is 87%, if the cut RMSF value was set at 0.65 Å.
Four local RMSF minima could be seen with < 0.5 Å, corresponding to the α -helical regions (Fig. 6), i.e. the 
highly structured protein core. According to Fig. 6, which represents overlapped RMSF values of intact protein 
with its corresponding DRPs, local mobility of DRPs demonstrates a similar pattern, including α -helical regions 
with RMSF minima. Figure 7 represents the 3D structure of overlapped intact protein with its corresponding 
DRP. In the DRPs, only a small conformational change could be observed, for Ara h 2 in the non-structured 
loop and the C-terminal region, and for Ara h 6 deviations are observed in the non-structured loop and the 
N-terminal region, while α -helical regions remained in their helical structure without any helical movement and 
rearrangement for all conglutin isoforms (Fig. 7), and even become slightly less dynamic. These results indicate 
that proteolysis does not substantially change the conformational stability of the proteins.
The root mean square deviation (RMSD) and radius of gyration of the DRPs was calculated by evaluating the 
spatial deviations in structure. This analysis further confirmed the compactness of DRPs (see Supplementary Figs 
S4 and S5). During the entire simulation time, DRPs of both Ara h 2 and Ara h 6 show a lower RMSD profile, 
suggesting that they are more stable than the corresponding intact proteins.
Figure 5. RMSF of intact conglutin isoforms with trypsin affected sites in DRPs (d,e,f). Top panels (a,b,c): 
Intact conglutins, lower panels (d,e,f): Trypsin affected sites in DRPs. Left panels (a,d): Ara h 2.02; Middle 
panels (b,e): Ara h 2.01; Right panels (c,f): Ara h 6.Arrows indicates place which are affected with trypsin; Blue 
line represent the protein sequence; Green lines represents the parts of protein sequences which contains  
α -helix as secondary structure; C represent cysteine which is involved in formation of disulphide bond.
Figure 6. RMSF variations of intact conglutin isoforms and DRPs. Panel a: Comparison of Ara h 2.02 and its 
DRP (Fig. 3a, peptide d); Panel b: Comparison of Ara h 6 and its DRP (Fig. 3c, peptide d). Arrows represent the 
minima of the RMSF which position is located in the α -helical region of the protein. Green lines represent the 
parts of protein sequences, which contain α -helix as secondary structure.
www.nature.com/scientificreports/
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Radius of gyration (Rg) values reveal a lower plot of DRPs during the whole simulation time and imply that 
DRPs have noticeably more compact conformation in comparison to intact protein. The more compact struc-
ture of DRPs than corresponding intact proteins (with more pronounced effect in the case of Ara h 2), as well as 
higher compactness of Ara h 6 than Ara h 2, is in accordance to changes in protein secondary structure elements 
during the simulation (see Supplementary Fig. S6) e.g. noticeably higher content of helixes in DRPs than in 
intact Ara h 2 proteins and higher content of helixes in Ara h 6 than in Ara h 2. This can be explained by the loss 
of non-structured amino acid sequences resulting in a higher fraction of structured elements in the digestion 
products.
Digestion-resistant peptides exhibit IgE-binding properties like native conglutin isoforms. 
The IgE-binding of DRPs from Ara h 2 and Ara h 6 was assessed by 2D gel electrophoresis combined with immu-
noblotting. Figure 8a shows that the three isoforms gave rise to IgE-binding spots. DRPs of Ara h 6 have more 
acidic pIs than DRPs from Ara h 2 isoforms. IgE-immunoblotting also reveals additional spots with higher molec-
ular weights. This represents a small fraction of intact Ara h 6, which remains after 90 min of digestion, as noted 
on SDS-PAGE and 2-DE. Spots that did not bind IgE (at < 10 kDa and with acidic pI) appeared to originate from 
Ara h 6 (Fig. 8a and Supplementary Fig. S2).
Figure 7. 3D structure of DRP overlapped with intact protein. Panel a: Ara h 2.02; Panel b: Ara h 6. The 
structure in red represents conformation of intact proteins and the structure in blue represent DRP (peptide d 
from Fig. 3a,c). Arrows show cleavage sites, indicating that the non-structured parts are affected.
Figure 8. IgE-binding properties of DRPs in comparison with native peanut conglutin isoforms. Panel a: 
2-D electrophoresis (left) and 2-D electrophoresis wit IgE Immunoblot of DRPs from Ara h 2/ h 6 mixture. M: 
Molecular markers; Panel b-d: IgE-binding potency as determined by IgE-ELISA of digestion-resistant peptides 
(dashed lines) and native conglutin (solid lines). A typical example is shown (Panel b: Ara h 2.02; Panel c: Ara h 
2.01; Panel d: Ara h 6). IgE binding potencies of DRPs are similar to those of intact conglutins.
www.nature.com/scientificreports/
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Additionally the IgE-binding potency of DRPs compared to that of intact peanut conglutin was assessed on a 
quantitative level by IgE-ELISA. Figure 8 (panels b–d) shows the inhibition plots of Ara h 2.02, Ara h 2.01, and 
Ara h 6 and their DRPs. For Ara h 2.02 and Ara h 6, the inhibition plots of DRPs are virtually overlapping with 
those of the intact proteins. For Ara h 2.01, there is a small shift to higher concentration, suggesting a slightly 
lower IgE-binding potency. From three independent experiments, the mean IC50 values (the concentration 
needed to inhibit 50% of the signal) were obtained and the fold increase in IC50 value between DRPs and intact 
proteins was determined. For Ara h 2.02, Ara h 2.01, and Ara h 6, this fold increase was 0.8 (± 0.4), 1.4 (± 1.4), and 
1.5 (± 0.6), respectively. As these numbers are close to 1, it can be concluded that the IgE-binding potency of all 
three peanut conglutin isoforms is not affected by trypsinolysis.
Discussion
Peanut conglutins Ara h 2 and Ara h 6 are known to be resistant to pepsin proteolysis under gastric condi-
tions20,23,30 and trypsin/chymotrypsin proteolysis under intestinal conditions13,20,26. Digestion with either of both 
proteases yields DRPs with apparent molecular weights similar to that of the native protein13,23, indicating that the 
actual susceptible cleavage sites for digestive proteases are determined by factors other than by protease specificity 
alone.
In this study, we obtained DRPs from conglutin isoforms with the molecular weights ranging from 5 to 10 kDa, 
that are held together by disulphide bonds and form a tight digestion-resistant core with a mass slightly lower than 
native conglutins, in line with earlier publications13,20,21,26. We have elucidated the complete sequences of DRPs 
and show for all three conglutin isoforms that except for the cleavage of the N-terminal part from the C-terminal 
part, heterogeneity in digestion occurs. This is in line with the 3D model for Ara h 6 and super-positioning of Ara 
h 2 onto it26, which confirms that the region with observed cleavage heterogeneity matches with non-structured 
parts. Furthermore, the size of the peptides derived corresponds with the size of the non-structured segments of 
the different conglutin isoforms. In contrast to Ara h 2, the C-terminus of Ara h 6 is not processed by trypsin due 
to cysteine residues involved in a disulphide bond (Cys84-Cys124) that limits the accessibility of Arg123. Regardless 
of the observed heterogeneity in DRPs, it is clear that most potential cleavage sites remain unperturbed even upon 
prolonged digestion. Most of these potential protease cleavage sites appear to reside in close proximity of the 
cysteine-residues. It is thus likely that such sites are inaccessible to the active site of trypsin due to steric hindrance 
by disulphide bonds, and their location in the compact tightly coiled core, CXnCXnCCXnCXCCXnC, typical 
for 2S albumins31. Indeed, 2S albumins from Brazil nut32, sesame seed33, sunflower34, cashew35, and hazelnut36 all 
exhibit a poor digestibility under gastro-intestinal conditions.
Our far UV CD data confirm that the secondary structure of the proteins is stable at both neutral and acidic 
pH and preserved after prolonged digestion with trypsin. To further analyse the conformation and stability of the 
fold of identified DRPs, a molecular dynamics simulation was performed on the modeled 3D structures of DRPs. 
The molecular dynamics simulation of DRPs demonstrated that the conformationally vibrant regions, such as the 
internal non-structured loop in Ara h 6 and Ara h 2.02, as well as the termini of the proteins, represent the main 
proteolysis target sites. In contrast, the most rigid regions are those in the immediate vicinity of Cys residues that 
form disulfide bridges, as well as regions in α -helical conformation. Although these regions contain numerous 
cleavage sites for trypsin they remain resistant for a prolonged time.
Trimming-off the non-structured parts of the conglutins by proteolysis leads to relatively more structured 
and more stable DRPs. This effect is greater for Ara h 2 than for Ara h 6, because Ara h 2 has a higher content of 
non-structured amino acid sequences. It is interesting to note that the difference between intact conglutin and 
DRPs is the smallest for Ara h 6, due to a smaller content of non-structured amino acid sequences and the pres-
ence of one extra disulphide bond compared to Ara h 2. One could suggest that the DRPs of the different conglu-
tin isoforms are more similar than their native counterparts, which may explain functional similarities while clear 
differences on the protein structural level are observed. Although for 2S albumins from other legumes, seeds, and 
nuts the cleavage sites are not fully known, it can be suggested that proteolysis of very diverse 2S albumins may 
result in DRPs with highly comparable structures because non-structural parts are cleaved-off.
It was shown previously that digested Ara h 213 and Ara h 621 were still able to bind IgE. In this study, we 
show that DRPs of both conglutins have the same IgE-binding potency as their intact counterparts. The retained 
IgE-binding potency, combined with the preserved protein structure, supports the hypothesis that IgE-binding 
to conglutins is primarily dependent on conformational epitopes17,37 and suggests that linear IgE epitopes in the 
non-structured areas, as identified by Stanley38, are less relevant.
Apart from the IgE-binding aspects, the digestive stability of allergens is also associated with higher immuno-
genicity, i.e. the potential to induce an immune response on a cellular level39. Recently it was also shown that con-
formational stability of allergens is a determinant for immunogenicity40. Our data show that peanut conglutins 
Ara h 2 and Ara h 6 fulfill both criteria; they confer stability toward digestion, combined with a high structural 
stability of the resulting DRPs, and may thus provide an explanation for extraordinary allergenicity of peanut 
conglutins.
This work identified and elucidated the structures of DRPs of naturally occurring isoforms of peanut conglu-
tins. We have shown that proteolysis targets reside in highly vibrant parts of the proteins. The DRPs resemble their 
native counterparts in terms of folding, conformational stability, and IgE-binding. These stability attributes allow 
DRPs to enter the small intestine to trigger the gut immune system, and to be taken up in circulation eliciting 
systemic allergic reactions.
We propose that conformational stability and resistance towards digestion may be the structural basis for the 
allergenicity of peanut conglutins Ara h 2 and Ara h 6, and other similarly structured 2S albumins.
www.nature.com/scientificreports/
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Methods
Trypsin digestion of peanut conglutin isoforms. Trypsin immobilized onto magnetic beads was used 
(ClonTech Laboratories Inc., Mountain View, CA, USA, product number 635646). The activity of trypsin was 
determined using the substrate alpha-benzoyl-L-arginine ethyl ester (BAEE, Sigma-Aldrich Corp., B4500, St. 
Louis, MO, USA), according to the instructions of the substrate manufacturer. The activity of the immobilized 
trypsin suspension (specification of the manufacturer > 150 U/ml) was 218 U/ml. A comparison of activity with 
soluble trypsin was made in order to express the trypsin concentration of the immobilized trypsin in μ g/ml. 
Thereto, trypsin (Sigma-Aldrich, product number T-1426, with a claimed specific activity of 10,000 U/mg), was 
assayed for specific activity of 9,560 U/mg. The activity of the immobilized trypsin of 218 U/ml corresponds to 
22.8 μ g/ml of trypsin in the stock suspension. Purified Ara h 2.01, Ara h 2.02, and Ara h 6, as well as a mixture of 
Ara h 2 and Ara h 6, were diluted to 0.5 mg/ml with 6.5 mM Tris-HCl pH 8 with the final volume of 1 ml. Thirty 
μ l of a suspension of trypsin immobilized onto magnetic beads was added to the protein solution, corresponding 
to a final trypsin concentration of 0.68 μ g/ml. Samples were incubated at 37 °C in an incubator shaker (1400 rpm). 
At different time points, aliquots were taken, beads separated from the solution using a magnet outside the vial, 
and the samples were then analysed on SDS-PAGE under reducing conditions. 2 μ g of digested material were run 
on 12% Bis-Tris gels with MES buffer using conditions set out by the manufacturer (Bio Rad, Hercules, CA, USA). 
DRPs obtained after 90 minutes of trypsin digestion were used for further analysis.
Mass spectrometry analysis. DRPs were analysed on EASY nanoLC II system coupled with LTQ Orbitrap 
XL (Thermo Fisher Scientific Inc., Waltham, Massachusetts, USA), previously calibrated with the ProteoMass™ 
LTQ/FT-Hybrid ESI Positive Mode Cal Mix (MSCAL5 SUPELCO, Sigma-Aldrich) calibration set. Samples were 
also analysed under reducing and alkylating condition. Reduction and alkylation of the DRPs was done as previ-
ously described for peanut conglutins17. Two microliters (concentration of 50 μ g/ml) of each sample was injected 
onto the trapping column (EasyColumn C18, 2 cm length, ID 100 μ m, 5 μ m particle size) and separation was 
performed on an Easy spray PepMap C18, (length 15 cm, ID 75 μ m, particle size 3 μ m) as described17. Spray was 
generated with a stainless steel emitter, with tip voltage set at 2.35 kV, capillary voltage 6 V and capillary temper-
ature of 275 °C. A high-resolution full Fourier-Transform Mass Spectrometry (FTMS) profile spectrum (scan 
range 300–3000 m/z, resolving power 60 000, 1 microscan) was acquired using Xcalibur (version 2.1) software 
(Thermo Fisher Scientific) with the precursor mass tolerance of 10 ppm. The experiments were done in duplicate.
Determination of digestion-resistant peptides. Prediction of the sequences of the DRPs was based 
according to the exact masses obtained by MS and exact masses of the native isoforms, using the peptide calcula-
tor tool (http://pepcalc.com/). For theoretical mass calculation in the peptide calculator, amino acid sequences for 
conglutin isoforms (Uniprot Q6PSU2-1, Q6PSU2-4 and Q647G9) were used, including the sequence conflicts. To 
take into account hydroxylation of proline as a posttranslational modification, partial reduction and alkylation, a 
mass addition of 16 Da for each Pro46, Pro53 and Pro65, and 57 Da for each alkylated Cys, were used19. For locating 
potential trypsin-cleavage sites, the ExPaSy PeptideCutter tool was used41.
Circular dichroism spectroscopy. Far UV circular dichroism (CD) spectra of proteins and DRPs (concen-
tration of 250 μ g/ml in 6.5 mM Tris-HCl (pH 8) and in 6.5 mM Tris-HCl containing 63 mM hydrochloric acid 
(pH 1.2)) were recorded on a JASCO J-815 spectrometer (JASCO, Tokyo, Japan) at 37 °C at a spectral resolution 
of 0.5 nm at a scan rate of 100 nm/min over the wavelength range from 190–260 nm. Each spectrum was acquired 
sixteen times and the results were averaged. The experiments were performed in duplicate.
De-novo modeling and molecular dynamic simulations. Sequences of two isoforms of Ara h 2 were 
obtained from UniProt (www.uniprot.org, identifiers Q6PSU2-1 and Q6PSU2-2). The missing regions in the Ara 
h 2.01 partial crystal structure (PDB code 3OB4) were built using Rosetta all-atom de-novo loop modeling proce-
dure42, more specifically fragment-based loop modeling using kinematic closure (KIC)43. A total of 10 000 mod-
eled structures were generated. More information about conformational space of missing regions was obtained by 
clustering the modeled structures by structural similarity. The lowest energy representative of the most populated 
cluster was taken for MD simulation.
The quality of obtained models were checked with programs ERRAT44 and PROCHECK45. Initial structures 
of the proteins for molecular dynamic simulations were obtained from Rosetta de novo modeling for Ara h 2.01 
and Ara h 2.02 isoforms and from PDB (PDB code 1W2Q, model #1) for Ara h 6 protein. Structures of DRPs were 
obtained by deleting the trypsin cleaved amino-acids from the protein structure: for Ara h 2.02 peptide d from 
Fig. 3a, for Ara h 6 peptide d from Fig. 3c. The protonation state of each titratable amino-acid was estimated using 
H+ + program46. Molecular dynamics (MD) calculations were performed with NAMD 2.9 program47 using the 
CHARMM27 force field48. Starting structures were solvated in a rectangular periodic box of TIP3P water mole-
cules, with Na+ and Cl− ions added to counter the total charge of the protein. Next, the system was subjected to 
extensive six-step equilibration protocol49, followed by 10 ns of NPT dynamics.
After equilibration, system was set to production run in NPT dynamics using the Langevin piston pressure 
control at 310 K and 1.01325 bar. Periodic boundary conditions and the Particle Mesh Ewald (PME) method 
were applied for a complete electrostatic calculation. The cut-off for non-bonded interactions was set to 9 Å, and 
switching function at 8 Å. Production phase was carried out with time step of 2 fs.
Root Mean Square Deviation (RMSD), Root Mean Square Fluctuations (RMSF) and Radius of gyration (Rg) 
were calculated in program VMD50 (version 1.9.2). For RMSF calculations a window of 20 frames width moving 
over trajectory was used. A STRIDE algorithm51 was used for analysing secondary structure changes over simu-
lation time. Molecular graphics were created with the UCSF Chimera package52 (version 1.10.2). All calculations 
were done on PARADOX computer cluster.
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2-DE and immunoblotting of digestion-resistant peptides. DRPs from individual or a mix of 
conglutins were diluted in rehydration buffer (6 M urea, 2 M thiourea, 2% CHAPS, 0.5% IPG buffer 3–10NL, 
0.002% bromophenol blue and 50 mM DTT). Separation of peptides on the first dimension was carried out on an 
Ettan-IPGphor system (GE Healthcare, Uppsala, Sweden) according to manufacturer’s instruction. The samples 
(18.75 μ g) were loaded on 13 or 7 cm immobilized pH gradient strips pH 3–10NL (GE Healthcare). After isoe-
lectrofocusing strips were incubated for 15 minutes in 2D equilibration buffer (6 M urea, 75 mM Tris HCl pH 8.8, 
29.3% glycerol, 2% SDS, 0.002% bromophenol blue) containing 10 mg/ml of DTT, and after that in equilibration 
buffer containing 25 mg/ml iodoacetamide, for 15 minutes in the dark. The second dimension was carried out 
on 16% gels. Imaging of the protein spots was performed with a Typhoon 7000 series laser scanner coupled with 
the Image 2D Master Platinum 7.0 software (GE Healthcare). In addition, DRPs from the conglutin mix were 
separated on 2-DE and transferred onto polyvinylidene fluoride (PVDF) membranes (Bio Rad). The membranes 
were blocked with 1% BSA in 20 mM Tris containing 0.9% NaCl pH 7.4 containing 0.05% Tween 20 (TBS-T), for 
3 h at room temperature (RT). Subsequently, membrane was incubated overnight at 4 °C with 1:5 diluted serum 
pool from patients with proven peanut allergy. The serum pool was made from sera of seven peanut allergic 
patients (range and mean of total peanut-specific IgE: 53–787 kU/L and 254 kU/L respectively; range and mean of 
Ara h 2-specific IgE: 27–317 kU/L and 117 kU/L, respectively). Bound IgE was detected with mouse anti-human 
IgE antibody conjugated with alkaline phosphatase, diluted 1:2000 (Sigma-Aldrich), by incubation for 1 h at 
RT. The binding patterns were visualized with a substrate solution consisting of 1.5 mg 5-bromo-4-chloro-3′- 
indolyphosphate (BCIP) and 3 mg nitro-blue tetrazolium (NBT) in 10 mL of 100 mM Tris, containing 150 mM 
NaCl, and 5 mM MgCl2, pH 9.6.
IgE binding properties of digestion-resistant peptides. The IgE binding properties of the native aller-
gens and DRPs were analysed using an inhibition ELISA. The microtiter plates (NUNC MaxiSorp, Nunc A/S 
Plastfabrikation, Roskilde, Denmark) were coated with 100 μ l of 5 μ g/ml native proteins per well in coating buffer 
(15 mM Na2CO3, 35 mM NaHCO3 pH 9.6) and incubated overnight at 4 °C. The remaining binding sites were 
blocked with 1% BSA in TBS-T for 1 h at RT. A dilution series of the samples in 0.1% BSA in TBS-T was incubated 
with the serum pool (the same serum pool as was used for immunoblotting, diluted 100-fold), directly on the 
plate for 1 h at RT. The concentration range of allergens was 0.004–10 μ g/ml. Detection was performed by incu-
bation with 100 μ l mouse-anti-human IgE monoclonal antibody (Abcam, UK, 2000 times diluted in TBS-T con-
taining 0.1% BSA) conjugated to horseradish peroxidase for 1 h at RT and 3,3′ ,5,5′ -tetramethylbenzidine (TMB) 
as substrate. The concentration needed to inhibit 50% of the signal was used to compare IgE-binding potencies 
of samples (IC50 value).
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